Lisata Therapeutics (LSTA) Equity Ratio (2016 - 2025)
Lisata Therapeutics' Equity Ratio history spans 13 years, with the latest figure at 0.82 for Q4 2025.
- For Q4 2025, Equity Ratio fell 1.76% year-over-year to 0.82; the TTM value through Dec 2025 reached 0.82, down 1.76%, while the annual FY2025 figure was 0.82, 1.76% down from the prior year.
- Equity Ratio reached 0.82 in Q4 2025 per LSTA's latest filing, up from 0.79 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.93 in Q2 2023 to a low of 0.79 in Q3 2025.
- Average Equity Ratio over 3 years is 0.87, with a median of 0.88 recorded in 2024.
- The largest YoY upside for Equity Ratio was 1.76% in 2025 against a maximum downside of 10.12% in 2025.
- A 3-year view of Equity Ratio shows it stood at 0.88 in 2023, then fell by 4.35% to 0.84 in 2024, then decreased by 1.76% to 0.82 in 2025.
- Per Business Quant, the three most recent readings for LSTA's Equity Ratio are 0.82 (Q4 2025), 0.79 (Q3 2025), and 0.83 (Q2 2025).